Losartan in post-transplant erythrocytosis.
Conlon
P J
PJ
Smith
S R
SR
Butterly
D W
DW
Brennan
D C
DC
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D019808:Losartan; D011086:Polycythemia / Q000209:etiology* / Q000517:prevention & control; D013777:Tetrazoles / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D019808:Losartan